Award
BPA #36E79726A0027
Blanket Purchase Agreement for Vyvgart Hytrulo by Argenx US, Inc.
Buyer
Department of Veterans Affairs
Award Amount
$703,256,709.16
Ceiling
$703,256,709.16
Awarded
September 12, 2026
Period of Performance
Sep 12, 2026 – Sep 11, 2027
Identifier
36E79726A0027
NAICS
325412
This award is a blanket purchase agreement (BPA) awarded to Argenx US, Inc., a biotechnology company specializing in innovative treatments, for the procurement of Vyvgart Hytrulo, a pharmaceutical product. The contract supports the agency's ongoing efforts to secure vital medical therapies, enhancing healthcare provisions. The scope covers the supply and delivery of Vyvgart Hytrulo under a streamlined purchasing framework, enabling efficient access to this critical medication. This BPA was awarded following competitive procedures and builds upon a previous long-term Federal Supply Schedule contract with Argenx US that facilitated the incorporation of new pharmaceutical products. The agreement has a multi-year performance period with an expected continuation of service. No key subcontractors or additional solicitation details have been provided.
Description
BPA FOR VYVGART HYTRULO